For example, Lox is upregulated in glioma (da Silva et al., 2015), and knockdown or inhibition of Lox can compromise tumor migration, invasion, and angiogenesis (Kim et al., 2014; Kore et al., 2018; Mammoto et al., 2013). This evidence concerns the gene LOX and central nervous system cancer.